August 1, 2022
Via: PharmaphorumThe updated vaccine will specifically target the BA.4 and BA.5 subvariants of Omicron which are currently driving a new wave of infections around the world. Moderna’s current clinical data is for a shot based on the original Wuhan strain of […]
July 28, 2022
Via: World Pharma NewsNew research shows that a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection. The findings were published in mBio, an open access journal of the American Society for Microbiology. In recent years, the Food and Drug […]
July 27, 2022
Via: PharmaphorumThe vaccine, codenamed BNT162b5, codes for “enhanced” prefusion spike proteins from the original wild-type strain of the virus and the Omicron variant that are designed to increase “the magnitude and breadth of the immune response.” The phase 2 trial will […]
July 27, 2022
Via: Drugs.comWith 19,000 cases now reported in 75 countries, the World Health Organization declared the monkeypox outbreak a global “public health emergency,” its highest level of health alert. The day after that announcement, New York City’s Bronx High School of Science […]
July 27, 2022
Via: PMLiVEThe National Institute of Allergy and Infectious Diseases (NIAID) director specifically detailed the call for pan-coronavirus candidates and mucosal options that can be given to patients intranasally, all the while reinforcing that “innovative approaches are clearly needed to induce broad […]
July 20, 2022
Via: PMLiVEThe biopharmaceutical industry has launched a declaration proposing a joint solution to global leaders that could help to ensure equitable access to vaccines and treatments for future pandemics. The ‘Berlin Declaration – biopharmaceutical industry vision for equitable access in pandemics’ […]
July 18, 2022
Via: PharmaphorumConvidencia’s injectable version was granted World Health Organization (WHO) Emergency Use Listing (EUL), and its inhalant counterpart, currently in phase three clinical trials, has shown enormous promise. “We’re bringing a solution, which is needle-free (so no pain at the point […]
July 1, 2022
Via: Drugs.comFallout is mounting for the food delivery service Daily Harvest, which has voluntarily recalled a frozen food product suspected of sickening hundreds of customers in at least 26 states. The U.S. Food and Drug Administration is investigating. And an Oklahoma […]
July 1, 2022
Via: PharmaphorumKerendia (finerenone) – a non-steroidal, selective mineralocorticoid receptor (MR) antagonist – has been shown to reduce the risk of kidney disease progression or renal death by 18% when added to the highest tolerated dose of standard therapy in the FIDELIO-DKD […]
June 29, 2022
Via: PharmaphorumCOVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. However, this picture of recovery hides a […]
June 29, 2022
Via: PharmaphorumAfter hours of deliberation, the panellists voted by 19 to two in favour of using redesigned booster shots, rather than simply using the currently authorised vaccines – although there was broad acknowledgement that the decision comes on the back of […]
June 24, 2022
Via: Drugs.comNearly two-thirds of the world’s population has had at least one COVID-19 vaccine, which has prevented nearly 20 million deaths, new research finds. The study from Imperial College London was the first to quantify the impact of vaccines on a […]
June 23, 2022
Via: PharmaphorumThe news came hard on the heels of Moderna’s announcement that it will build a research and manufacturing facility in the UK to produce COVID and other mRNA jabs, and an additional order for 60 million doses that could be […]
June 22, 2022
Via: PharmaphorumOne of these – dubbed V116 – is a cocktail of 21 Streptococcus pneumoniae serotypes designed to have the most benefit in adult populations, and it has just cleared a phase 1/2 trial as it embarks on a phase 3 […]
June 21, 2022
Via: Biopharm InternationalThe European Medicines Agency (EMA) has begun a rolling review of the Spikevax vaccine that has been adapted to protect against two variant strains of SARS-CoV-2, the agency announced on June 17, 2022. The review will focus on non-clinical laboratory […]
June 20, 2022
Via: Drugs.comAfter a final sign-off on Saturday from the head of the U.S. Centers for Disease Control and Prevention, COVID-19 vaccines for children younger than 5 have finally become a reality. “This expands eligibility for vaccination to nearly 20 million additional […]
Clinical Trials, Research and Development
June 17, 2022
Via: PharmaphorumThe company says it plans to use a “flexible” model, drawing on both decentralised trial (DCT) and conventional site-based models via its Health Corner and Village Medical outlets at various Walgreens locations across the US. The move follows in the […]
June 17, 2022
Via: Biopharm InternationalA broad bill carrying multiple proposals for revising and expanding FDA programs and policies, in addition to reauthorizing user fees critical for funding FDA operations, was endorsed by the Senate Health, Education, Labor and Pensions (HELP) Committee this week. The […]
June 16, 2022
Via: PharmaphorumThe Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 21 to zero in favour of both vaccines in this age group, in light of rising rates of hospitalisations and deaths that have been seen in the very young during […]
Industry, Manufacturing, Research and Development, Vaccines
June 15, 2022
Via: PMLiVEWhen vaccines became available earlier in the COVID-19 pandemic, countries vied for supply contracts. However, as the need for vaccines begins to slow in Europe, some countries want to amend their contracts to reduce spending and to prevent receiving more […]